Human epidermal growth factor receptor targeted inhibitors for the treatment of ovarian cancer

Human epidermal growth factor receptor targeted inhibitors for the treatment of ovarian cancer

Ovarian cancer is the second most lethal gynecological cancer worldwide and while most patients respond to initial therapy, they often relapse with resistant disease. Human epidermal growth factor receptors (especially HER1/EGFR and HER2/ERBB2) are involved in disease progression; hence, strategies...

Full description

Bibliographic Details
Main Authors: Maria Bonello, Andrew Harvey Sims, Simon Peter Langdon
Format: Article
Language:English
Published: China Anti-Cancer Association 2018-12-01
Series:Cancer Biology & Medicine
Subjects:
Tyrosine kinase
monoclonal antibodies
ovarian cancer
inhibitors
HER
receptors
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/1291

Internet

http://www.cancerbiomed.org/index.php/cocr/article/view/1291

Similar Items